|
Volumn 11, Issue 6, 2011, Pages 22-23
|
The dangers of using a relative risk standard for minimal risk
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ADOLESCENT;
ARTICLE;
CHILD BEHAVIOR;
CLINICAL TRIAL (TOPIC);
ETHICS;
HIGH RISK BEHAVIOR;
HUMAN;
HUMAN EXPERIMENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
METHODOLOGY;
PARTICIPATORY RESEARCH;
PATIENT SELECTION;
PRIMARY PREVENTION;
RISK;
SOUTH AFRICA;
UNITED STATES;
VULNERABLE POPULATION;
ADOLESCENT;
ADOLESCENT BEHAVIOR;
AIDS VACCINES;
BALTIMORE;
CLINICAL TRIALS AS TOPIC;
COMMUNITY-BASED PARTICIPATORY RESEARCH;
HIV INFECTIONS;
HUMANS;
NONTHERAPEUTIC HUMAN EXPERIMENTATION;
PATIENT SELECTION;
PRIMARY PREVENTION;
RISK;
RISK-TAKING;
SOUTH AFRICA;
UNITED STATES;
VULNERABLE POPULATIONS;
|
EID: 79959206940
PISSN: 15265161
EISSN: 15360075
Source Type: Journal
DOI: 10.1080/15265161.2011.572511 Document Type: Article |
Times cited : (7)
|
References (8)
|